These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 662438)

  • 1. [Characteristics of the antitoxic immunity in children with scarlatina treated at home].
    Koliagina NT; Kapkovaia ZI; Staodub NS
    Pediatr Akus Ginekol; 1978; (2):18-9. PubMed ID: 662438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical laboratory characteristics of scarlatina in children kept under home isolation].
    Koliagina NT; Kapkova ZI
    Pediatr Akus Ginekol; 1978; (3):21-3. PubMed ID: 673507
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complications of scarlatina and their causes].
    Koliahina NT
    Pediatr Akus Ginekol; 1978; (6):5-6. PubMed ID: 733387
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of antitoxic immunity in patients with scarlatina according to passive hemagglutination reaction data].
    Silich VA; Fiks LI; Dodonov VN; Sezonova EP; Novik ZA
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):19-23. PubMed ID: 4590982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative characteristics of the immunologic structure of children's collectives as regards scarlatina in different climatic zones].
    Silich VA; Dodonov VN; Fiks LI; Severov AM; Strel'tsova NA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):62-6. PubMed ID: 125514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the correlation between various biological and environmental factors and the conversion of sensitivity to streptococcal erythrotoxin in children belonging to organised collectives].
    Ivan IM; Horhogea G; Mihalcou F; Tisu A; Decă N
    Arch Roum Pathol Exp Microbiol; 1967 Sep; 26(3):677-84. PubMed ID: 5591586
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Dick reaction. Its use and evolution during treatment in scarlatina].
    Nauciel C
    Pathol Biol; 1967 May; 15(9):519-22. PubMed ID: 4864911
    [No Abstract]   [Full Text] [Related]  

  • 8. [Frequency and clinical characteristics of complications in scarlatina in children].
    Moshchich PS
    Pediatr Akus Ginekol; 1973; 6():10-1. PubMed ID: 4544886
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the general immunological reactivity of the body].
    Simonian BA
    Zh Eksp Klin Med; 1972; 12(2):43-8. PubMed ID: 4575507
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitoxic immunity and allergic reactions in scarlet fever in various seasons; regional characteristics of the development of antitoxic immunity in scarlet fever].
    MUSABAEV IK; KHAMIDOV SKh
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):64-7. PubMed ID: 13282459
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of antitoxin immunity in scarlet fever].
    Fiks LI; Bliumental' KV; Silich VA; Dodonov VN; Sezonova EP
    Pediatriia; 1972 Feb; 51(2):44-8. PubMed ID: 5036295
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dynamics of antitoxic immunity to hemolytic Streptococcus in enclosed children's institutions].
    Silich VA; Fiks LI; Dodonov VN; Severov AM; Cherkasskaia RS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):139-40. PubMed ID: 149480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Variations of the Dick reaction in school children with and without various streptococcal antecedents].
    Ivan IM; Horhogea G; Mihalcu F; Tisu A; Petrescu R
    Pediatria (Bucur); 1965; 14(4):295-301. PubMed ID: 5862888
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scarlet fever in childhood--1969].
    Ocklitz HW; Padelt H
    Zentralbl Bakteriol Orig; 1970; 214(3):428-39. PubMed ID: 5534040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of dyspensary observation of children who sustained Far Eastern scarlatina-like fever (pseudotuberculosis)].
    Gordeets AV; Meniakina LI; Ivanova LS
    Vopr Okhr Materin Det; 1978 Oct; 23(10):84. PubMed ID: 706290
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibodies to erythrogenic toxin B in scarlatina patients].
    Silich VA; Fiks LI; Dodonov VN; Sezonova EP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):112-5. PubMed ID: 1092101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Course and immunogenesis of scarlet fever in children with staphylococcal carrier state].
    Kaliagina NT
    Pediatriia; 1979 Jan; (1):22-4. PubMed ID: 432025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in antistreptococcal antibodies in scarlet fever].
    Hamd SS; Guasco C
    G Mal Infett Parassit; 1967 Jun; 19(6):382-6. PubMed ID: 6051990
    [No Abstract]   [Full Text] [Related]  

  • 19. [Level of natural isoagglutinins in diseased children according to age groups].
    Szczepańska H; Zalewska I
    Pediatr Pol; 1971 Jan; 46(1):7-12. PubMed ID: 5545828
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-immunological aspects of scarlet fever today].
    Timofeeva GA; Ostrovskiĭ AD; Antipova LA; Eronina MF
    Pediatriia; 1984 Mar; (3):10-4. PubMed ID: 6609342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.